West Pharmaceutical Services (WST)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$2.96 (+1.04%)Past Day

About

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Key Insights

  • Share Price

    $285.28
  • Market Cap

    $20.69 Billion
  • Total Outstanding Shares

    72.54 Million Shares
  • Total Employees

    10,600
  • Dividend

    $0.2 Per Share Quarterly
  • IPO Date

    October 27, 1980
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Homepage

    https://www.westpharma.com

Historical Stock Splits

If you bought 1 share of WST before September 27, 2013, you'd have 2 shares today.
Execution DateSplit Amount
September 27, 20132-for-1

Cash Flow Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$752.40 Million
Net Cash Flow, Continuing$-345.00 Million
Net Cash Flow From Operating Activities$752.40 Million
Net Cash Flow$-361.50 Million
Net Cash Flow From Financing Activities$-701.10 Million
Net Cash Flow From Investing Activities$-396.30 Million
Net Cash Flow From Financing Activities, Continuing$-701.10 Million
Net Cash Flow From Investing Activities, Continuing$-396.30 Million

Income Statement

July 1, 2023 to June 30, 2024
MetricValue
Cost Of Revenue$1.85 Billion
Benefits Costs and Expenses$2.27 Billion
Gross Profit$1.03 Billion
Basic Average Shares$147.50 Million
Income/Loss Before Equity Method Investments$611.30 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Net Income/Loss Available To Common Stockholders, Basic$524.90 Million
Diluted Earnings Per Share$7.03
Other Operating Expenses$20.90 Million
Costs And Expenses$2.27 Billion
Income Tax Expense/Benefit$102.20 Million
Selling, General, and Administrative Expenses$348.70 Million
Research and Development$69.90 Million
Operating Income/Loss$587.20 Million
Revenues$2.88 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income/Loss From Continuing Operations After Tax$513.40 Million
Net Income/Loss Attributable To Parent$524.90 Million
Operating Expenses$439.50 Million
Nonoperating Income/Loss$24.10 Million
Diluted Average Shares$149.10 Million
Income/Loss From Equity Method Investments$15.80 Million
Net Income/Loss$524.90 Million
Basic Earnings Per Share$7.11
Income/Loss From Continuing Operations Before Tax$611.30 Million
Preferred Stock Dividends And Other Adjustments$0.00

Balance Sheet

July 1, 2023 to June 30, 2024
MetricValue
Equity Attributable To Parent$2.58 Billion
Current Liabilities$633.70 Million
Liabilities And Equity$3.49 Billion
Other Current Assets$1.06 Billion
Accounts Payable$211.70 Million
Other Non-current Assets$499.80 Million
Long-term Debt$205.80 Million
Current Assets$1.48 Billion
Inventory$419.20 Million
Assets$3.49 Billion
Noncurrent Liabilities$278.90 Million
Fixed Assets$1.49 Billion
Liabilities$912.60 Million
Noncurrent Assets$2.01 Billion
Other Non-current Liabilities$73.10 Million
Equity Attributable To Noncontrolling Interest$0.00
Equity$2.58 Billion
Other Current Liabilities$422.00 Million
Intangible Assets$12.90 Million

Historical Dividends

Current dividend: $0.2 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Apr 25, 2024Aug 7, 2024Jul 31, 2024$0.2Quarterly
Feb 20, 2024May 1, 2024Apr 24, 2024$0.2Quarterly
Dec 6, 2023Feb 7, 2024Jan 31, 2024$0.2Quarterly
Oct 26, 2023Nov 15, 2023Nov 8, 2023$0.2Quarterly
Apr 27, 2023Aug 2, 2023Jul 26, 2023$0.19Quarterly
Mar 3, 2023May 3, 2023Apr 26, 2023$0.19Quarterly
Dec 13, 2022Feb 1, 2023Jan 25, 2023$0.19Quarterly
Oct 27, 2022Nov 16, 2022Nov 9, 2022$0.19Quarterly
Apr 28, 2022Aug 3, 2022Jul 20, 2022$0.18Quarterly
Feb 23, 2022May 4, 2022Apr 20, 2022$0.18Quarterly
Jan 5, 2022Feb 2, 2022Jan 19, 2022$0.18Quarterly
May 5, 2021Aug 4, 2021Jul 21, 2021$0.17Quarterly
Feb 24, 2021May 5, 2021Apr 21, 2021$0.17Quarterly
Dec 9, 2020Feb 3, 2021Jan 20, 2021$0.17Quarterly
Oct 28, 2020Nov 18, 2020Nov 11, 2020$0.17Quarterly
Jul 15, 2020Aug 5, 2020Jul 29, 2020$0.16Quarterly
Feb 25, 2020May 6, 2020Apr 22, 2020$0.16Quarterly
Dec 13, 2019Feb 5, 2020Jan 22, 2020$0.16Quarterly
Jul 25, 2019Nov 6, 2019Oct 23, 2019$0.16Quarterly
May 8, 2019Aug 7, 2019Jul 24, 2019$0.15Quarterly
Feb 21, 2019May 1, 2019Apr 17, 2019$0.15Quarterly
Dec 18, 2018Feb 6, 2019Jan 23, 2019$0.15Quarterly
May 3, 2018Nov 7, 2018Oct 24, 2018$0.15Quarterly
May 3, 2018Aug 1, 2018Jul 18, 2018$0.14Quarterly
Feb 15, 2018May 2, 2018Apr 18, 2018$0.14Quarterly
Jul 20, 2017Nov 1, 2017Oct 18, 2017$0.14Quarterly
May 15, 2017Aug 2, 2017Jul 19, 2017$0.13Quarterly
Feb 16, 2017May 3, 2017Apr 19, 2017$0.13Quarterly
Dec 14, 2016Feb 1, 2017Jan 18, 2017$0.13Quarterly
Sep 12, 2016Nov 2, 2016Oct 19, 2016$0.13Quarterly
Jul 5, 2016Aug 3, 2016Jul 20, 2016$0.12Quarterly
Mar 4, 2016May 4, 2016Apr 20, 2016$0.12Quarterly
Dec 17, 2015Feb 3, 2016Jan 20, 2016$0.12Quarterly
Jul 14, 2015Nov 4, 2015Oct 21, 2015$0.12Quarterly
Jul 1, 2015Aug 5, 2015Jul 22, 2015$0.11Quarterly
Feb 20, 2015May 6, 2015Apr 22, 2015$0.11Quarterly
Dec 16, 2014Feb 4, 2015Jan 21, 2015$0.11Quarterly
Jul 15, 2014Nov 5, 2014Oct 22, 2014$0.11Quarterly
May 6, 2014Aug 6, 2014Jul 23, 2014$0.1Quarterly
Feb 20, 2014May 7, 2014Apr 23, 2014$0.1Quarterly
Dec 19, 2013Feb 5, 2014Jan 22, 2014$0.1Quarterly
Aug 1, 2013Nov 6, 2013Oct 23, 2013$0.1Quarterly
May 10, 2013Aug 7, 2013Jul 24, 2013$0.19Quarterly
Feb 19, 2013May 1, 2013Apr 17, 2013$0.19Quarterly
Dec 27, 2012Feb 6, 2013Jan 23, 2013$0.19Quarterly
Oct 1, 2012Nov 7, 2012Oct 24, 2012$0.19Quarterly
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.